                         SEQUENCE LISTING

<110>  The Trustees of Columbia University in the City of New York
 
<120>  THERAPEUTICS FOR COVID-19

<130>  91291-A-PCT/JPW/GJG/BI

<140>  PCT/US2021/015672
<141>  2021-01-29

<150>  62/967,452
<151>  2020-01-29

<150>  62/968,011
<151>  2020-01-30

<150>  62/972,803
<151>  2020-02-11

<150>  62/983,272
<151>  2020-02-28

<150>  62/984,190
<151>  2020-03-02

<150>  62/988,798
<151>  2020-03-12

<150>  62/991,508
<151>  2020-03-18

<150>  63/001,155
<151>  2020-03-27

<150>  63/013,432
<151>  2020-04-21

<150>  63/063,171
<151>  2020-08-07

<150>  63/070,231
<151>  2020-08-25

<150>  63/130,303
<151>  2020-12-23

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  RNA template-loop-primer for biotin-dUTP, Stavudine-TP or AZT-TP 
       extension reactions

<400>  1
uuuucuacgc guaguuuucu acgcg                                             25


<210>  2
<211>  25
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  RNA template-loop-primer for Carbovir-TP or Ganciclovir-TP 
       extension reactions

<400>  2
uuuucuccgc guaguuuucu acgcg                                             25


<210>  3
<211>  25
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  RNA template-loop-primer for Tenofovir-DP extension reactions

<400>  3
uuuucuucgc guaguuuucu acgcg                                             25


